Physician

Adam Kunkis, MD, MBA

According to 2025 Medicare claims, Adam Kunkis, MD, MBA (NPI: 1790216588) practices family practice in the Newark, NJ market, with the plurality of this provider's patient population coming from Morris, NJ. This provider's primary affiliated billing organization is PRIMARY CARE PARTNERS LLC (NPI: 1083900526; TIN: 274980253) and primary practice location at 07405-2351. Kunkis is affiliated with the Atlantic ACO (ACO ID: A1026) and ColigoCare, LLC (ACO ID: A3591), participating under the MSSP model.

Kunkis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 232 traditional Medicare patients, billed 819 HCPCS/CPT codes, and received $62,383 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 733 prescription claims across 173 beneficiaries totaling $58,616 in drug costs, led by Ozempic (Semaglutide). Open Payments data shows 38 records totaling $656. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $9,279 to $62,383. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,681 to $58,616. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	84	149	$9,279
2021	319	535	$38,500
2022	280	581	$43,075
2023	365	701	$42,858
2024	232	819	$62,383

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	21	83	$10,681
2019	20	111	$8,416
2020	72	151	$12,109
2021	180	361	$23,631
2022	235	379	$7,084
2023	341	524	$8,020
2024	173	733	$58,616

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	123	123	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	74	147	$106
99497	Advance care planning, first 30 minutes	140	141	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	86	114	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	59	98	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	20	784	$22,628
Rosuvastatin Calcium	Rosuvastatin Calcium	28	2,530	$599
Albuterol Sulfate Hfa	Albuterol Sulfate	20	488	$542
Levothyroxine Sodium	Levothyroxine Sodium	37	3,041	$467
Ezetimibe	Ezetimibe	17	1,490	$361

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$656	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Kunkis, MD, MBA?

Tedicare shows public-source Medicare data for Adam Kunkis, MD, MBA (NPI 1790216588), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Kunkis, MD, MBA have ACO affiliation data?

Adam Kunkis, MD, MBA is shown with ACO affiliation data for Atlantic ACO (MSSP, ACO ID A1026) and ColigoCare, LLC (MSSP, ACO ID A3591).

What billing organization is linked to Adam Kunkis, MD, MBA?

Adam Kunkis, MD, MBA is linked to PRIMARY CARE PARTNERS LLC (billing NPI 1083900526) in the available physician profile data.

Does Adam Kunkis, MD, MBA have Open Payments data?

Adam Kunkis, MD, MBA has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.